Investitionsthese
The Blue Venture Fund invests in healthcare innovation to improve patient outcomes and operational efficiency for Blue Cross Blue Shield members. Leveraging deep industry relationships and payor expertise, it supports companies that redesign care delivery, enhance health plan operations, and advance clinical decision-making.
Investitionsphase
Seed to Growth to Buyout (Stage Agnostic)
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Technology, services, and clinical sciences companies driving better health outcomes and cost reduction for Blue Plan Members
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
k.A.
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...